Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Published Online: 2020-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Adrian G Murphy•Andrew X Zhu•Anthony B El-Khoueiry•Bin Fan•Bin Wu•Camelia Gliser•Christina X Chamberlain•Daniel V Catenacci•Do-Youn Oh•Ghassan K Abou-Alfa•James M Cleary•John Bridgewater•Jonathan Whisenant•Jorge Adeva•Juan W Valle•Liewen Jiang•Lipika Goyal•Maeve A Lowery•Milind M Javle•Mitesh J Borad•Rachna T Shroff•Robin K Kelley•Sam J Lubner•Shuchi S Pandya•Teresa Macarulla•William P Harris
